Edition:
United States

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

5.05USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.05
Open
$5.10
Day's High
$5.20
Day's Low
$4.95
Volume
36,901
Avg. Vol
77,988
52-wk High
$9.25
52-wk Low
$4.80

Chart for

About

Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. The Company's commercial product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic and related variants of... (more)

Overall

Beta: --
Market Cap(Mil.): $241.33
Shares Outstanding(Mil.): 45.53
Dividend: --
Yield (%): --

Financials

  SBBP.OQ Industry Sector
P/E (TTM): -- 28.87 33.05
EPS (TTM): -2.97 -- --
ROI: -86.48 13.59 13.17
ROE: -556.53 15.31 15.10

BRIEF-Strongbridge To Host Conference Call On March 12 To Announce Fourth Quarter And Year-End 2017 Results

* STRONGBRIDGE BIOPHARMA PLC TO HOST CONFERENCE CALL ON MARCH 12, 2018 TO ANNOUNCE FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Feb 28 2018

BRIEF-Strongbridge Biopharma Announces Pricing Of Public Offering

* STRONGBRIDGE BIOPHARMA PLC ANNOUNCES PRICING OF PUBLIC OFFERING OF ORDINARY SHARES

Jan 25 2018

BRIEF-Strongbridge Biopharma Announces Proposed Public Offering Of 5 Mln Ordinary Shares

* STRONGBRIDGE BIOPHARMA PLC ANNOUNCES PROPOSED PUBLIC OFFERING OF 5 MILLION ORDINARY SHARES Source text for Eikon: Further company coverage:

Jan 23 2018

Earnings vs. Estimates